|
|
7329495 |
Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors
The present invention relates to methods and compositions concerning resistance to a drug for cancer comprising aberrant KIT signal, such as aberrant KIT sequence or expression. In a specific...
|